世界の職業性呼吸器疾患市場 – 業界動向と2030年までの予測

職業性呼吸器疾患市場の分析と規模

職業性呼吸器疾患の罹患率の増加、喫煙人口の増加、大気汚染の増加は、市場の成長を促進する要因となるでしょう。しかし、厳格な価格設定と償還ポリシー、薬剤の高コストは、職業性呼吸器疾患市場を抑制するでしょう。               

データブリッジマーケットリサーチは、2022年に93億801万米ドルだった世界の職業性呼吸器疾患市場は、2030年までに151億7480万米ドルに達し、2023年から2030年の予測期間中に6.30％のCAGRを達成すると予測しています。これは、さまざまな用途の迅速およびインプラント薬と治療法の開発につながった技術の進歩により、アスベスト症セグメントが世界の職業性呼吸器疾患市場の疾患タイプセグメントを支配していることを示しています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、データブリッジマーケットリサーチがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

職業性呼吸器疾患市場の範囲とセグメンテーション

Market Definition

Occupational respiratory disorders, also known as work-related respiratory diseases, are a group of conditions that are caused or exacerbated by exposure to hazardous substances or conditions in the workplace. These disorders affect the respiratory system, including the lungs, airways, and related structures.

Global Occupational Respiratory Disorders Market Dynamics

Drivers

• Increasing Awareness

There has been a growing awareness among workers and employers about the risks associated with occupational respiratory disorders. This has led to an increased demand for preventive measures and early diagnosis of respiratory disorders, driving the market growth.

• Increasing Industrialization

The rapid industrialization in emerging economies has resulted in a higher number of workers being exposed to occupational respiratory hazards. This has created a greater demand for respiratory protective equipment and monitoring devices, driving the market growth.

• Occupational Health and Safety Initiatives

Several organizations and companies have started implementing comprehensive occupational health and safety programs to protect their workforce from respiratory hazards. This includes regular health check-ups, training on the proper use of respiratory protective equipment, and monitoring of workplace air quality. These initiatives have contributed to the growth of the market.

Opportunities

• Technological Advancements

The development of advanced respiratory monitoring devices, such as portable spirometers, wearable devices, and real-time air quality monitoring systems, has significantly contributed to the growth of the market. These devices offer accurate and real-time monitoring of respiratory parameters, aiding in early diagnosis and treatment of respiratory disorders.

• Growing Healthcare Expenditure

The increasing healthcare expenditure globally has led to improved access to healthcare facilities and diagnostic services. This has positively impacted the demand for diagnostic tests and treatment options for occupational respiratory disorders, driving the market growth.

Restraints/Challenges

• Workplace Monitoring and Measurement Equipment

This segment includes the development and sale of monitoring and measurement equipment that assesses air quality, particulate matter levels, and exposure to harmful substances. Innovations in real-time monitoring are driving growth in this area.

• Regulatory Compliance Solutions

Companies often invest in software and solutions that help them navigate and comply with occupational health and safety regulations related to respiratory hazards. These solutions assist in managing compliance records and safety data.

The global occupational respiratory disorders market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global occupational respiratory disorders market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In September 2021, 3M announced the launch of their new Powered Air Purifying Respirator (PAPR) system called Versaflo TR-600. This system is designed to provide respiratory protection for workers in various industries, including those at risk of occupational respiratory disorders
• In July 2021, Honeywell announced the expansion of their respiratory protection product line with the introduction of the North 7700 Series Half Mask. This mask is designed to provide a comfortable and secure fit, helping to protect workers from airborne contaminants in occupational settings

Global Occupational Respiratory Disorders Market Scope

The global occupational respiratory disorders market is segmented on the basis of disease type, cause, drugs type, severity, route of administration, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Type  

• Asbestosis
• Black Lung Disease
•  Silicosis
•  Byssinosis
•  Hypersensitivity Pneumonitis
• Work-Related Asthmaa
• Others

Cause

• Organic
• Inorganic

Drugs Type

• Mycolytics
• Antibiotics
• Corticosteriods
•  Antihistmains
• Others

Severity

• Acute
• Chronic

Route of Administration

•  Oral
• Nasal
• Parenteral

End User

• Hospitals
•  Specialty Clinics
•  Diagnostic Centers
•  Research Institute
•  Others

Distribution Channel

• Hospital Pharmacy
•  Retail Pharmacy
• Online Pharmacies
• Others

Global Occupational Respiratory Disorders Market Analysis/Insights

The global occupational respiratory disorders market is analyzed and market size insights and trends are provided by country, disease type, cause, drugs type, severity, route of administration, end user, and distribution channel as referenced above.

The countries covered in the global occupational respiratory disorders market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global occupational respiratory disorders market because of the strong base of healthcare facilities, strong presence of major players in the market, rising demand of the occupational respiratory disorders products, and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Occupational Respiratory Disorders Market Share Analysis

世界の職業性呼吸器疾患市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性が含まれます。提供されている上記のデータ ポイントは、世界の職業性呼吸器疾患市場に関連する会社の焦点にのみ関連しています。

世界の職業性呼吸器疾患市場で活動している主要企業は次のとおりです。

• グラクソ・スミスクライン社（英国）
• アストラゼネカ（英国）
• ノバルティスAG（スイス）
• ジョンソン・エンド・ジョンソン（米国）
• マイランNV（米国）
• ベーリンガーインゲルハイム GmbH (ドイツ)
• テバ製薬工業株式会社（イスラエル）
• ギリアド・サイエンシズ（米国）
• バイエルAG：ドイツ、レバークーゼン
• ファイザー社（米国）
• ブリストル・マイヤーズスクイブ（米国）
• メルク社（米国）
• サノフィ（フランス）
• マリンクロット社（英国）
• F. ホフマン・ラ・ロシュ社（スイス）
• バーテックス・ファーマシューティカルズ社（米国） 

SKU-60465